Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BetterLife Pharma Inc C.BETR

Alternate Symbol(s):  BETRF

BetterLife Pharma Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001 is a non-hallucinogenic Lysergic Acid Diethylamide (LSD) derivative. BETR-001 mimics the projected therapeutic properties of LSD without causing its undesirable side effects such as... see more

CSE:BETR - Post Discussion

BetterLife Pharma Inc > BetterLife Pharma Addresses Unmet Needs With Mental Health
View:
Post by londonfog1 on Dec 13, 2021 1:27pm

BetterLife Pharma Addresses Unmet Needs With Mental Health

BNN published an article this morning about BetterLife Pharma. This article talks about the company's involvement in proving LSD's efficacy in the treatment of major depressive disorders. 

BetterLife Pharma is a life sciences company creating and clinically validating an evolving intellectual property portfolio of novel molecules and drug delivery mechanisms for clinical trials and commercialization.

BetterLife recently created a proprietary process to manufacture 2-bromo-LSD, a patient-friendly version of LSD, for treating major depressive disorders that is completely free of controlled substances. The company is at the pre-clinical stage of development and is projecting to have its investigational new drug filing done within the next few months. 

Read the article here: https://www.bnnbloomberg.ca/the-next-generation-of-psychedelic-products-is-here-and-betterlife-pharma-is-leading-the-charge-1.1693495

Learn more about BetterLife here: https://abetterlifepharma.com/
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities